Quality Systems – Page 282

Sterility Test Failure post-sterile filtration: risk assessment for patient safety and recall

Assessing Risk and Investigating Sterility Test Failures After Sterile Filtration Sterility test failures following sterile filtration represent a significant concern within pharmaceutical manufacturing, particularly for parenteral dosage forms. Such events…

Cleaning Validation Failure during method transfer: mixing and sampling controls for QA review

Investigating Cleaning Validation Failures During Method Transfer: Key Controls and CAPA Insights In pharmaceutical manufacturing, especially in topical and dermatological dosage forms, maintaining rigorous cleaning validation protocols is critical. A…

Bioburden Spike Pre-Filtration during power interruption: facility, people, process root cause mapping

Investigating Bioburden Spikes Pre-Filtration During Power Interruptions in Pharmaceutical Manufacturing Bioburden spikes in pharmaceutical manufacturing, particularly during the pre-filtration stage, can pose significant risks to product quality and regulatory compliance.…

Filter Integrity Failure during aseptic filling: FDA/MHRA investigation narrative and batch impact

Investigation of Filter Integrity Failures During Aseptic Filling: An FDA/MHRA Perspective In pharmaceutical manufacturing, particularly within parenteral dosage forms, the integrity of filters during aseptic filling processes is critical. When…

Color Change after packaging change: complaint trending and risk-based actions

Investigating Color Change After Packaging Change in Pharmaceutical Manufacturing In pharmaceutical manufacturing, deviations in product appearance can signal significant underlying issues. A common scenario involves color changes in topical formulations…

Sterility Test Failure during routine EM trending: CAPA package with evidence and effectiveness checks

Sterility Testing Failure Investigations during Routine Environmental Monitoring Trending Sterility test failures during routine environmental monitoring (EM) can significantly disrupt pharmaceutical operations, compromising product safety and leading to regulatory scrutiny.…

Smoke Study Failure post-sterile filtration: facility, people, process root cause mapping

Root Cause Investigation of Smoke Study Failures After Sterile Filtration In the realm of pharmaceutical manufacturing, particularly in the production of sterile injectable products, a smoke study failure post-sterile filtration…

Assay Oos in cream manufacturing: complaint trending and risk-based actions

Investigating Assay OOS in Cream Manufacturing: Trending Complaints and Risk-Based Actions In the realm of pharmaceutical manufacturing, particularly within the cream and topical formulation sector, Out-of-Specification (OOS) results can pose…

Bioburden Spike Pre-Filtration during hold-time study: facility, people, process root cause mapping

Root Cause Mapping for Bioburden Spikes During Pre-Filtration in Hold-Time Studies In the realm of pharmaceutical manufacturing, particularly within sterile injectable production, bioburden control is critical. A bioburden spike during…

Sterility Test Failure after maintenance intervention: data integrity checks for lab and shop floor

Sterility Test Failure Following Maintenance Interventions: A Comprehensive Investigation Approach In the realm of pharmaceutical manufacturing, especially for parenteral dosage forms, the integrity of sterility testing is paramount. A reported…

Cleaning Validation Failure during inspection preparation: complaint trending and risk-based actions

Addressing Cleaning Validation Failures During Inspection Preparation: A Systematic Investigation Approach In the pharmaceutical manufacturing landscape, cleaning validation is crucial for ensuring that equipment is devoid of contaminants between batches,…

High Visual Inspection Reject Rate post-sterile filtration: facility, people, process root cause mapping

Investigating High Visual Inspection Reject Rates Following Sterile Filtration High visual inspection reject rates post-sterile filtration can significantly disrupt pharmaceutical operations, leading to increased costs, delays, and potential regulatory scrutiny.…